Allarity Therapeutics Inc

NAS:ALLR (USA)  
$ 0.80 +0.0457 (+6.06%) 03:12 PM EST
At Loss
Volume:
5.21M
Avg Vol (2M):
4.03M
Also Trade In:
Volume:
5.21M
At Loss
Avg Vol (2M):
4.03M

Business Description

Description
Allarity Therapeutics Inc is a clinical-stage, precision medicine company. The company is actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. Its Drug Response Predictor (DRP) technology refines patient selection and improves clinical outcomes. Its pipeline product includes Dovitinib, Stenoparib, Ixempra, and other formulations.
Name Current Vs Industry Vs History
Cash-To-Debt 0.13
Equity-to-Asset -0.23
Debt-to-Equity -0.47
Debt-to-EBITDA -0.12
Piotroski F-Score 1/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 51.8
3-Year EPS without NRI Growth Rate 44.8
3-Year FCF Growth Rate 52.8

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 14.38
9-Day RSI 13.31
14-Day RSI 13.78
6-1 Month Momentum % -61.85
12-1 Month Momentum % -98.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.14
Quick Ratio 0.14
Cash Ratio 0.01

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -266.1
Shareholder Yield % -10.37

Profitability Rank

Name Current Vs Industry Vs History
ROA % -89.6
ROIC % -124.75
ROC (Joel Greenblatt) % -44566.93
ROCE % -5549.02

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -0.42
EV-to-EBITDA -0.43
EV-to-FCF -0.37
Earnings Yield (Greenblatt) % -238.1
FCF Yield % -616.89